You are here

American Hospital Association Offers Value-Based Care Advice

New report tells post-acute care providers what they need to know

A new TrendWatch report from the American Hospital Association (AHA) says that post-acute care (PAC) providers play a key role in the transition from volume-based to value-based care.

In recent years, larger percentages of Medicare patients are being discharged to PAC settings, according to a FiereceHealthcare article on the report. For example, 17.3% were discharged to skilled nursing facilities in 2008, compared to 19.5% in 2013.

The increased proliferation of alternative payment models that involve shared risk among hospitals, PAC providers, and insurers means PAC providers must understand factors such as geographic PAC spending variation. This variation is due to several drivers, including broad variation in conditions, comorbidities, and medical severity; volume of patients discharged to PAC settings after short stays in acute hospital settings; and the amount and category of PAC services received during the care episode.

Major PAC providers have already made strides in improving or creating business models to make them better suited to a value-based care system. For example, RML Specialty Hospital, a Chicago long-term care hospital, focuses its accountable care organization’s  resources on highly-specialized care for patients admitted directly from a hospital who needed three days in an intensive care unit. RML also has joined multiple PAC continuing care networks, and is currently tracking data on patients discharged from the hospital for 180 days, which it will then use to compare the outcomes to those of patients discharged from other types of post-acute providers.

Source: FierceHealthcare, December 22, 2015.

Recent Headlines

Findings from ISCHEMIA trial may mean fewer stents and bypass operations for those with stable disease
Donors hope to vaccinate 450 million children each year
New Novartis drug cuts rate of crises by 45% relative to placebo
FDA says new Pentax design is easier to clean
Myovant’s drug would offer a new oral, once-daily treatment option
More research is needed to confirm the finding
Study shows "complex genetic risk architecture"
Study says yes, interventions cuts need for meds
Review of 18 studies finds that medium doses have the strongest effects